Subscribe
shutterstock_1506315968_sleepingpanda-1
sleepingpanda / Shutterstock.com
20 April 2021BiotechnologyThomas Moga

The curious case of Wuhan’s Institute of Virology and remdesivir

The Patent Law of the People’s Republic of China first went into effect on April 1, 1985. It has been amended three times with a fourth amendment scheduled to take effect on June 1, 2021.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Campaigners say US govt should have remdesivir patent rights
28 May 2020   The PrEP4All campaign has argued that the US government should own joint patent rights for remdesivir, the Gilead Sciences antiviral which is the only drug approved anywhere for treating COVID-19.
Asia
Indian police seize black market remdesivir, arrest 14
21 July 2020   Police in Mumbai and Hyderabad have arrested 14 people on suspicion of distributing black market remdesivir at five times its retail price.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Campaigners say US govt should have remdesivir patent rights
28 May 2020   The PrEP4All campaign has argued that the US government should own joint patent rights for remdesivir, the Gilead Sciences antiviral which is the only drug approved anywhere for treating COVID-19.
Asia
Indian police seize black market remdesivir, arrest 14
21 July 2020   Police in Mumbai and Hyderabad have arrested 14 people on suspicion of distributing black market remdesivir at five times its retail price.

More on this story

Americas
Campaigners say US govt should have remdesivir patent rights
28 May 2020   The PrEP4All campaign has argued that the US government should own joint patent rights for remdesivir, the Gilead Sciences antiviral which is the only drug approved anywhere for treating COVID-19.
Asia
Indian police seize black market remdesivir, arrest 14
21 July 2020   Police in Mumbai and Hyderabad have arrested 14 people on suspicion of distributing black market remdesivir at five times its retail price.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
ITC concludes row over biotech lab equipment between US and German rivals
‘Don’t stifle UK AI innovation’: King's speech on AI Act prompts warnings
FTC supports USPTO terminal disclaimer plan amid opposition
BlueAllele says rival gained $100m from Regeneron deal using patented tech